Produkty 32455-43-9

CAS 32455-43-9 występuje w naszej ofercie pod nazwami: 7–((β–D–Glucopyranosyl)oxy)–3'，4'，5，8–tetrahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-5,8-dihydroxy-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, ≥98%, ≥98%, Hypolaetin 7-glucoside, 99.00%. Oferty producentów: GLPBio, Chemat, MedChemExpress. Dostępne opakowania: 5mg, 10mg, 20mg, 5 mg, 1 mg.

7–((β–D–Glucopyranosyl)oxy)–3'，4'，5，8–tetrahydroxyflavone
GLPBio
  • opakowanie: 5mg
  • Warianty: 1
od 4355,48
Zobacz produkt
2-(3,4-Dihydroxyphenyl)-5,8-dihydroxy-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, ≥98%, ≥98%
Chemat
  • opakowanie: 5mg, 10mg, 20mg
  • Warianty: 3
od 3760,40
Zobacz produkt
Hypolaetin 7-glucoside, 99.00%
MedChemExpress
  • opakowanie: 5 mg, 1 mg
  • Warianty: 2
od 2181,94
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

2-(3,4-dihydroxyphenyl)-5,8-dihydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one (CAS 32455-43-9) to związek chemiczny o wzorze sumarycznym C21H20O12 i masie molowej 464.4 g/mol. Nazwa systematyczna IUPAC: 2-(3,4-dihydroxyphenyl)-5,8-dihydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one. InChIKey: BIPHTXZNUUXTIC-GHNMMOQISA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H20O12
Masa molowa464.4 g/mol
Nazwa IUPAC2-(3,4-dihydroxyphenyl)-5,8-dihydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
InChIKeyBIPHTXZNUUXTIC-GHNMMOQISA-N
SMILESC1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 8-Hydroxyluteolin 7-glucoside, Hypolaetin 7-glucoside, Hypolaetin 7-O-glucoside, orb1942627, 7-[(beta-D-Glucopyranosyl)oxy]-3',4',5,8-tetrahydroxyflavone, hypolaetin-7-O-beta-D-glucopyranoside, 7-[(|A-D-Glucopyranosyl)oxy]-3',4',5,8-tetrahydroxyflavone
Izomery (ten sam wzór sumaryczny)
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one C21H20O12
3-[(2S,3R,4R,5R)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one C21H20O12
(2S,3S,4S,5R,6S)-6-[[(2R)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-2,3-dihydrochromen-7-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C21H20O12
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one C21H20O12
3,5,7-trihydroxy-2-[3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one C21H20O12
3,5,7-trihydroxy-2-[4-hydroxy-3-[(2S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one C21H20O12
(2S,3S,4S,5R,6S)-6-[[(2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-2,3-dihydrochromen-7-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C21H20O12
5,6,7-trihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one C21H20O12